Delivery Order SPE2DB22D2007-SPE2DB24FJ4LX

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,378.46, is for the delivery of 4565154078 citalopram HBR 40 mg tablets. The contract has a firm fixed price structure and has an ultimate completion date of July 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,292.87, is for the delivery of 500 units of Citalopram HBR 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,330.09, is for the delivery of 4,567,767,109 units of Citalopram HBR 40 mg tablets. The contract has a period of performance ending on April 2, 2025 and is a firm fixed-price delivery order. This award is not associated with any set-aside designation. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,575.14, is for the delivery of Citalopram HBR 40 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,958.23, is a delivery order for 4,562,704,033 units of Citalopram HBR 40 mg tablets. The contract has a firm fixed price and an ultimate completion date of November 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,997,639 units of the prescription drug citalopram HBR 40 mg tablets in 500-count bottles. The total ceiling value of the contract is $13,501.13, with an ultimate completion date of January 22, 2025. This appears to be a delivery order contract with a firm fixed-price pricing type....
This federal contract award, valued at $1,166.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,873,359 tablets of the medication Citalopram HBR 40 mg, with a completion date of April 11, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,231.79, is for the delivery of 4560863511 Citalopram HBR 40 mg tablets in 100-count bottles. The contract has a completion date of May 9, 2023 and is a Firm Fixed Price Delivery Order. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $13,586.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,077 units of the prescription medication Citalopram Hydrobromide 40 mg tablets. The contract has an ultimate completion date of October 11, 2024 and is structured as a firm-fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds several large...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,458.06 firm fixed-price delivery order is for the supply of 4562911580 - Citalopram HBR 40 mg Tablets, 500 count, with a performance period through November 28, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4LX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,335.40, is for the delivery of 500 units of the prescription drug Citalopram HBR 40 mg tablets. This is a firm fixed-price delivery order contract, with a completion date of July 25, 2024. The contract was awarded on July 24, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:01 AM